PlaqueTec

Stub active Updated Apr 27, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Cambridge, UK
Founded 2012
Latest Stage Growth
Total Raised $13M+
Website https://www.plaquetec.com
Sector
biotech medtech cardiovascular precision-medicine diagnostics

About

PlaqueTec is a Cambridge UK-based medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease and enable precision medicine for coronary artery disease 12. The April 2026 oversubscribed financing was funded entirely by the company’s existing investor base 1.

Funding History

Date Round Amount Lead Co-investors
2024-04-30 Equity financing £6.4M (~$8M) Lord Moynihan of Chelsea Future Fund, existing investors 3
2026-04-27 Growth financing $5M Existing investor base 12

What Investors Say

No independently sourced investor quotes found.

What Founders Say

No independently sourced founder quotes found.

Sources

  1. BioSpace, “PlaqueTec Closes $5 Million Financing,” April 27, 2026. https://www.biospace.com/press-releases/plaquetec-closes-5-million-financing↩↩↩

  2. EU-Startups, “Cambridge’s PlaqueTec raises €4.2 million to advance precision medicine for cardiovascular disease,” April 27, 2026. https://www.eu-startups.com/2026/04/cambridges-plaquetec-raises-e4-2-million-to-advance-precision-medicine-for-cardiovascular-disease/↩↩

  3. UKTech.News, “PlaqueTec secures £6.4 million investment led by Lord Moynihan of Chelsea,” April 30, 2024. https://www.uktechnews.info/2024/04/30/plaquetec-secures-6-4-million-investment-led-by-lord-moynihan-of-chelsea/↩